Clinical Trial Update: Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on glutamine for prevention of radiation toxicity in breast cancer patients undergoing therapy; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: University of Arkansas | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-05-29